No Data
No Data
Innovative Healthcare (002173.SZ): Net loss of 2,977,900 yuan in the first quarter
On April 26, Ge Longhui | Innovative Healthcare (002173.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 201 million yuan, down 1.40 from the previous year; net profit attributable to shareholders of listed companies - RMB 2,977,900; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses - RMB 2.7087 million; and basic earnings per share - 0.0067 yuan.
Innovative Healthcare (002173.SZ): Net loss of 34.2877 million yuan in 2023
On April 12, Ge Longhui (002173.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 806 million yuan, an increase of 13.51% over the previous year; net profit attributable to shareholders of listed companies was -34,287,700 yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was -280.26 million yuan; and basic earnings per share -0.08 yuan.
Sanxin Medical (300453.SZ): The products of the holding subsidiary passed the innovative medical device review
Sanxin Medical (300453.SZ) announced that recently, Jiangxi Colevide Biotechnology Co., Ltd., a holding subsidiary of the company...
Aibo Healthcare (688050.SH): Product passed a special review process for innovative medical devices
Gelonghui, April 2 | Aibo Medical (688050.SH) announced that the company's “artificial lens” recently passed the Special Examination Procedure for Innovative Medical Devices by the Medical Device Technology Review Center of the State Drug Administration (Innovation Review Acceptance Number: CQTS2400048). This product is an artificial lens with the effect of extending depth of field. While providing farsightedness comparable to that of ordinary single-focus intraocular lenses, patients can benefit from useful medium- and near-vision. Currently, all domestic depth-of-field intraocular lens products rely on imports. The extended depth of field intraocular lens products developed by the company is based on many innovations
Innovative Medical ManagementLtd (SZSE:002173) Shareholders Are Still up 35% Over 3 Years Despite Pulling Back 9.2% in the Past Week
One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger returns, and build a portfolio ourselves. For example, Innovative Medical Management C
Guojin Securities: Medical equipment updates are expected to accelerate demand for high-end innovative medical equipment is expected to be released
It is recommended to focus on segments such as surgical robotics, endoscopes, ultrasound, and ICU equipment.
No Data